Wells Fargo’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-9,679
Closed -$548K – 6954
2022
Q1
$548K Sell
9,679
-18,855
-66% -$984K ﹤0.01% 4339
2021
Q4
$1.48M Buy
+28,534
New +$1.47M ﹤0.01% 3786
2021
Q3
– Sell
-11,313
Closed -$702K – 7067
2021
Q2
$702K Buy
+11,313
New +$754K ﹤0.01% 4437

Other funds holding EHC

Wells Fargo's EHC Position: Q2 2026 in Review

Wells Fargo increased its Encompass Health (EHC) stake by 14% in Q2 2026, buying an estimated $2.52M and bringing the position to 197,760 shares worth $20M. The position accounts for ﹤0.01% of the portfolio, ranked #1638.

Wells Fargo first reported a position in EHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $141M in Q3 2018. 598 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Wells Fargo held 197,760 shares of Encompass Health worth $20M as of Q2 2026.
  • Wells Fargo bought 24,347 Encompass Health shares in Q2 2026, an estimated $2.52M.
  • Encompass Health made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1638 holding.
  • Wells Fargo first reported a position in Encompass Health in Q2 2013 and has held it in 53 quarters since.
  • Wells Fargo's Encompass Health position peaked at $141M in Q3 2018.
  • 598 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.